A longitudinal study of the peripheral and central auditory pathways in individuals with acute lymphoid leukemia

Detalhes bibliográficos
Autor(a) principal: Vosgrau, Jéssica Sales
Data de Publicação: 2023
Outros Autores: Silva, Liliane Aparecida Fagundes, Odone Filho, Vicente, Matas, Carla Gentile
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/214032
Resumo: Objective: To characterize the peripheral and central auditory pathways in individuals with Acute Lymphoid Leukemia (ALL) and compare assessment results before and during chemotherapy. Method: The study included 17 subjects with ALL, divided into two age groups: 3 to 6 (11 individuals) and 7 to 16 years old (6 individuals). Each subject was evaluated twice (before and 3 to 6 months after chemotherapy treatment) with the following procedures: medical history survey, otoscopy, Pure-Tone Threshold (PTA) and speech audiometry, acoustic immittance measures, Brainstem Auditory Evoked Potentials (BAEP) and Long-Latency Auditory Evoked Potentials (LLAEP). Results: PTA was normal. Tympanometry was abnormal in the second assessment in 2 individuals aged 3 to 6 years. One subject in each age group had absent ipsilateral acoustic reflexes. In high-frequency audiometry, 1 individual had abnormal results. BAEP was abnormal in 5 (first assessment) and 7 individuals (second assessment) aged 3 to 6 years and 2 (first assessment) and 1 individual (second assessment) aged 7 to 16 years. As for LLAEP, P1 latency was increased in 5 (first assessment) and 7 individuals (second assessment) aged 3 to 6 years. Conclusion: No hearing loss was identified in the behavioral audiological assessment. BAEP was more affected in the 3-to-6-year-old group, with greater impairment in the lower brainstem in the first and second assessments. In LLAEP, P1 was the most impaired component in children aged 3 to 6 years, and P2 and N2 were so for those 7 to 16 years old, especially in the second assessment.
id USP-19_9b5f880c29d1d461a01c69d3de7c6018
oai_identifier_str oai:revistas.usp.br:article/214032
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling A longitudinal study of the peripheral and central auditory pathways in individuals with acute lymphoid leukemiaAuditory evoked potentialsAuditory perceptionHearingLeukemia-lymphoblastic precursor cell lymphomaPharmacological treatmentObjective: To characterize the peripheral and central auditory pathways in individuals with Acute Lymphoid Leukemia (ALL) and compare assessment results before and during chemotherapy. Method: The study included 17 subjects with ALL, divided into two age groups: 3 to 6 (11 individuals) and 7 to 16 years old (6 individuals). Each subject was evaluated twice (before and 3 to 6 months after chemotherapy treatment) with the following procedures: medical history survey, otoscopy, Pure-Tone Threshold (PTA) and speech audiometry, acoustic immittance measures, Brainstem Auditory Evoked Potentials (BAEP) and Long-Latency Auditory Evoked Potentials (LLAEP). Results: PTA was normal. Tympanometry was abnormal in the second assessment in 2 individuals aged 3 to 6 years. One subject in each age group had absent ipsilateral acoustic reflexes. In high-frequency audiometry, 1 individual had abnormal results. BAEP was abnormal in 5 (first assessment) and 7 individuals (second assessment) aged 3 to 6 years and 2 (first assessment) and 1 individual (second assessment) aged 7 to 16 years. As for LLAEP, P1 latency was increased in 5 (first assessment) and 7 individuals (second assessment) aged 3 to 6 years. Conclusion: No hearing loss was identified in the behavioral audiological assessment. BAEP was more affected in the 3-to-6-year-old group, with greater impairment in the lower brainstem in the first and second assessments. In LLAEP, P1 was the most impaired component in children aged 3 to 6 years, and P2 and N2 were so for those 7 to 16 years old, especially in the second assessment.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2023-06-24info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/21403210.1016/j.clinsp.2023.100234Clinics; Vol. 78 (2023); 100234Clinics; v. 78 (2023); 100234Clinics; Vol. 78 (2023); 1002341980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/214032/196269Copyright (c) 2023 Clinicsinfo:eu-repo/semantics/openAccessVosgrau, Jéssica SalesSilva, Liliane Aparecida FagundesOdone Filho, VicenteMatas, Carla Gentile2023-07-06T13:05:40Zoai:revistas.usp.br:article/214032Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2023-07-06T13:05:40Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv A longitudinal study of the peripheral and central auditory pathways in individuals with acute lymphoid leukemia
title A longitudinal study of the peripheral and central auditory pathways in individuals with acute lymphoid leukemia
spellingShingle A longitudinal study of the peripheral and central auditory pathways in individuals with acute lymphoid leukemia
Vosgrau, Jéssica Sales
Auditory evoked potentials
Auditory perception
Hearing
Leukemia-lymphoblastic precursor cell lymphoma
Pharmacological treatment
title_short A longitudinal study of the peripheral and central auditory pathways in individuals with acute lymphoid leukemia
title_full A longitudinal study of the peripheral and central auditory pathways in individuals with acute lymphoid leukemia
title_fullStr A longitudinal study of the peripheral and central auditory pathways in individuals with acute lymphoid leukemia
title_full_unstemmed A longitudinal study of the peripheral and central auditory pathways in individuals with acute lymphoid leukemia
title_sort A longitudinal study of the peripheral and central auditory pathways in individuals with acute lymphoid leukemia
author Vosgrau, Jéssica Sales
author_facet Vosgrau, Jéssica Sales
Silva, Liliane Aparecida Fagundes
Odone Filho, Vicente
Matas, Carla Gentile
author_role author
author2 Silva, Liliane Aparecida Fagundes
Odone Filho, Vicente
Matas, Carla Gentile
author2_role author
author
author
dc.contributor.author.fl_str_mv Vosgrau, Jéssica Sales
Silva, Liliane Aparecida Fagundes
Odone Filho, Vicente
Matas, Carla Gentile
dc.subject.por.fl_str_mv Auditory evoked potentials
Auditory perception
Hearing
Leukemia-lymphoblastic precursor cell lymphoma
Pharmacological treatment
topic Auditory evoked potentials
Auditory perception
Hearing
Leukemia-lymphoblastic precursor cell lymphoma
Pharmacological treatment
description Objective: To characterize the peripheral and central auditory pathways in individuals with Acute Lymphoid Leukemia (ALL) and compare assessment results before and during chemotherapy. Method: The study included 17 subjects with ALL, divided into two age groups: 3 to 6 (11 individuals) and 7 to 16 years old (6 individuals). Each subject was evaluated twice (before and 3 to 6 months after chemotherapy treatment) with the following procedures: medical history survey, otoscopy, Pure-Tone Threshold (PTA) and speech audiometry, acoustic immittance measures, Brainstem Auditory Evoked Potentials (BAEP) and Long-Latency Auditory Evoked Potentials (LLAEP). Results: PTA was normal. Tympanometry was abnormal in the second assessment in 2 individuals aged 3 to 6 years. One subject in each age group had absent ipsilateral acoustic reflexes. In high-frequency audiometry, 1 individual had abnormal results. BAEP was abnormal in 5 (first assessment) and 7 individuals (second assessment) aged 3 to 6 years and 2 (first assessment) and 1 individual (second assessment) aged 7 to 16 years. As for LLAEP, P1 latency was increased in 5 (first assessment) and 7 individuals (second assessment) aged 3 to 6 years. Conclusion: No hearing loss was identified in the behavioral audiological assessment. BAEP was more affected in the 3-to-6-year-old group, with greater impairment in the lower brainstem in the first and second assessments. In LLAEP, P1 was the most impaired component in children aged 3 to 6 years, and P2 and N2 were so for those 7 to 16 years old, especially in the second assessment.
publishDate 2023
dc.date.none.fl_str_mv 2023-06-24
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/214032
10.1016/j.clinsp.2023.100234
url https://www.revistas.usp.br/clinics/article/view/214032
identifier_str_mv 10.1016/j.clinsp.2023.100234
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/214032/196269
dc.rights.driver.fl_str_mv Copyright (c) 2023 Clinics
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 Clinics
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 78 (2023); 100234
Clinics; v. 78 (2023); 100234
Clinics; Vol. 78 (2023); 100234
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222767410315264